Jennifer E. Towne, Seattle, WA (US); Janet D. Cheng, Montclair, CA (US); Jason C. O'Neill, Brier, WA (US); Yu Zhang, Shoreline, WA (US); Yu Sun, Seattle, WA (US); Heather Cerne, Seattle, WA (US); Derek E. Piper, Santa Clara, CA (US); and Randal R. Ketchem, Snohomish, WA (US)
Assigned to AMGEN INC., Thousand Oaks, CA (US)
Filed by AMGEN INC., Thousand Oaks, CA (US)
Filed on Nov. 12, 2021, as Appl. No. 17/525,421.
Application 17/525,421 is a division of application No. 17/229,607, filed on Apr. 13, 2021, abandoned.
Application 17/229,607 is a continuation of application No. 17/060,905, filed on Oct. 1, 2020, abandoned.
Application 17/060,905 is a continuation of application No. 16/793,610, filed on Feb. 18, 2020, abandoned.
Application 16/793,610 is a continuation of application No. 16/453,482, filed on Jun. 26, 2019, abandoned.
Application 16/453,482 is a continuation of application No. 16/194,896, filed on Nov. 19, 2018, abandoned.
Application 16/194,896 is a continuation of application No. 15/922,675, filed on Mar. 15, 2018, abandoned.
Application 15/922,675 is a continuation of application No. 15/271,315, filed on Sep. 21, 2016, granted, now 9,951,129.
Application 15/271,315 is a continuation of application No. 14/228,556, filed on Mar. 28, 2014, granted, now 9,487,580.
Application 14/228,556 is a continuation of application No. 13/504,449, granted, now 8,722,033, previously published as PCT/US2010/054148, filed on Oct. 26, 2010.
Claims priority of provisional application 61/381,287, filed on Sep. 9, 2010.
Claims priority of provisional application 61/254,982, filed on Oct. 26, 2009.
Prior Publication US 2022/0056122 A1, Feb. 24, 2022
1. A method for treating Crohn's disease comprising administering to a patent in need thereof an effective amount of an antibody that binds IL-23, wherein the antibody comprises a heavy chain variable region of SEQ ID NO: 31 and a light chain variable region of SEQ ID NO: 1, and wherein the antibody is an IgG2 antibody.
